Grifols (GIFLF) Work In Process (2021)

Grifols (GIFLF) reported Work In Process of $2.2 million for Q4 2021.

Grifols (GIFLF) Work In Process (2021) Analysis & Trends

Grifols has reported Work In Process for 1 years, with the latest figure at $2.2 million in Q4 2021.

For the quarter ending Q4 2021, Work In Process changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2021 stood at $2.2 million (changed N/A YoY), and the FY2021 full-year result was $2.2 million, changed N/A from the prior year.
Work In Process for Q4 2021 stood at $2.2 million.
The five-year high for Work In Process was $2.2 million in Q4 2021, with the low at $2.2 million in Q4 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	96,436,181.12 Bn	96,436,176.16 Bn	7.76 Bn
2	Eli Lilly	1,017.30 Bn	1,012.01 Bn	16.22 Bn
3	Johnson & Johnson	579.61 Bn	557.55 Bn	15.96 Bn
4	AbbVie	402.30 Bn	392.96 Bn	10.78 Bn
5	Merck	294.24 Bn	288.59 Bn	12.09 Bn
6	Amgen	191.82 Bn	179.78 Bn	5.87 Bn
7	Gilead Sciences	155.93 Bn	148.21 Bn	5.52 Bn
8	Pfizer	149.05 Bn	136.28 Bn	-1.21 Bn
9	Bristol Myers Squibb	116.33 Bn	105.88 Bn	8.07 Bn
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2021	2.22 Mn